Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancer

Oncology (Switzerland)

Volumn 83, Issue 2, 2012, Pages 91-100

  Motoori, Masaaki ^a   Yano, Masahiko ^a   Yasuda, Takushi ^a   Miyata, Hiroshi ^b   Peng, Ying Feng ^a   Yamasaki, Makoto ^b   Shiraishi, Osamu ^a   Tanaka, Koji ^b   Ishikawa, Osamu ^a   Shiozaki, Hitoshi ^a   Doki, Yuichiro ^b  

^a KINKI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Enteral nutrition; Esophageal cancer; Immunological parameters; Neoadjuvant chemotherapy; Neutropenia

Indexed keywords

HLA DR ANTIGEN; PHYTOHEMAGGLUTININ;

ADULT; ADVANCED CANCER; ANTIGEN EXPRESSION; ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; ENTERIC FEEDING; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPENIA; PARENTERAL NUTRITION; PRIORITY JOURNAL; TH1 TH2 BALANCE;

ENTERAL NUTRITION; ESOPHAGEAL NEOPLASMS; FEMALE; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEUTROPENIA; TH1 CELLS; TH2 CELLS;

EID: 84863517688     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000339694     Document Type: Article

References (28)

1. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-372.
2. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733.
3. Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H: A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 2012; 19: 68-74.
4. Miyata H, Yano M, Yasuda T, Hamano R, Yamasaki M, Hou E, Motoori M, Shiraishi O, Tanaka K, Mori M, Doki Y: Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 2012; 31: 330-336.
5. Nichols PH, Ward U, Ramsden CW, Primrose JN: The effect of 5-fluorouracil and - interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer. Br J Cancer 1994; 70: 946-949. (Pubitemid 24331092)
6. Garzetti GG, Ciavattini A, Muzzioli M, Romanini C: Cisplatin-based polychemotherapy reduces the natural cytotoxicity of peripheral blood mononuclear cells in patients with advanced ovarian carcinoma and their in vitro responsiveness to interleukin-12 incubation. Cancer 1999; 85: 2226-2231. (Pubitemid 29215563)
7. Nowak AK, Robinson BW, Lake RA: Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. Cancer Res 2002; 62: 2353-2358. (Pubitemid 34411717)
8. Sakurai Y, Masui T, Yoshida I, Tonomura S, Shoji M, Nakamura Y, Isogaki J, Uyama I, Komori Y, Ochiai M: Randomized clinical trial of the effects of perioperative use of immune- enhancing enteral formula on metabolic and immunological status in patients undergoing esophagectomy. World J Surg 2007; 31: 2150-2157. (Pubitemid 47620215)
9. Takeuchi H, Ikeuchi S, Kawaguchi Y, Kitagawa Y, Isobe Y, Kubochi K, Kitajima M, Matsumoto S: Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg 2007; 31: 2160-2167. (Pubitemid 47620232)
10. Okamoto Y, Okano K, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y: Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg 2009; 33: 1815-1821.
11. Jho DH, Cole SM, Lee EM, Espat NJ: Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther 2004; 3: 98-111. (Pubitemid 38669043)
12. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F: Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998; 82: 395-402. (Pubitemid 28060258)
13. Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC: Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr 1999; 129: 1120-1125. (Pubitemid 29250159)
14. Kinsella JE, Lokesh B, Broughton S, Whelan J: Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990; 6: 24-44. (Pubitemid 20105664)
15. Sobin LH, Wittekind CH (eds): TNM Classification of Malignant Tumors, ed 6. New York, Wiley-Liss, 2002.
16. Miyata H, Yoshioka A, Yamasaki M, Nushijima Y, Takiguchi S, Fujiwara Y, Nishida T, Mano M, Mori M, Doki Y: Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 2009; 115: 3324-3334.
17. Motoori M, Yano M, Yasuda T, Miyata H, Peng YF, Yamasaki M, Shiraishi O, Masuzawa T, Tanaka K, Ishikawa O, Shiozaki H, Doki Y: Chemotherapy-induced toxicities and treatment efficacy in advanced esophageal cancer treated with neoadjuvant chemotherapy followed by surgery. Esophagus 2011; 8: 81-87.
18. Japanese Society for Esophageal Diseases: Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, ed 10. Tokyo, Kanehara Syuppan, 2007.
19. Mokart D, Capo C, Blache JL, Delpero JR, Houvenaeghel G, Martin C, Mege JL: Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002; 89: 1450-1456.
20. Tatsumi H, Ura H, Ikeda S, Yamaguchi K, Katsuramaki T, Asai Y, Hirata K: Surgical influence on Th1/Th2 balance and monocyte surface antigen expression and its relation to infectious complications. World J Surg 2003; 27: 522-528. (Pubitemid 36961119)
21. Matsuda A, Furukawa K, Takasaki H, Suzuki H, Kan H, Tsuruta H, Shinji S, Tajiri T: Preoperative oral immune-enhancing nutritional supplementation corrects Th1/Th2 imbalance in patients undergoing elective surgery for colorectal cancer. Dis Colon Rectum 2006; 49: 507-516.
22. Ono S, Ueno C, Aosasa S, Tsujimoto H, Seki S, Mochizuki H: Severe sepsis induces deficient interferon- and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis. Am J Surg 2001; 182: 491-497. (Pubitemid 34062847)
23. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ: Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80: 205-209. (Pubitemid 23084808)
24. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11: 161-167. (Pubitemid 38090671)
25. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer EJ, Wolff SM, Dinarello CA: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-271. (Pubitemid 19045549)
26. Wallace FA, Miles EA, Calder PC: Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br J Nutr 2003; 89: 679-689. (Pubitemid 36592094)
27. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ: The effect on human tumor necrosis factor- and interleukin-1 production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996; 63: 116-122. (Pubitemid 26005735)
28. Nagai H, Miyaki D, Matsui T, Kanayama M, Higami K, Momiyama K, Ikehara T, Watanabe M, Sumino Y, Miki K: Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy. Cancer Chemother Pharmacol 2008; 62: 959-963.